Genetic analysis indicates that
mei-2 behaves as an activator of
mei-1, a putative ATPase required for meiotic spindle function. All three
mei-2 mutations exhibit recessive maternal-effect lethality as a result of meiotic failure. However, the null phenotype of
mei-2 is currently unknown. Our goal is to clone and characterize
mei-2. The
mei-2 locus mapped to the left of
let-607 (which we rescued by transformation with cosmid F57B10) and to the right of the duplication hDp39, the endpoint of which lies within K06A5 (S. Clark-Maguire, pers. comm). Three overlapping cosmids that span the region from hDp39 to F57B10 (K06A5, M02H2, and C01B6) were found to rescue
mei-2(
ct102) when coinjected. The rescue was relatively weak, with twenty-fold more embryos surviving from cosmid-bearing
mei-2 mothers than embryos from non-cosmid-bearing
mei-2 mothers (20/2000 vs 1/2000). To date, all attempts to narrow down the smallest rescuing fragment via transformation rescue have failed (no pairwise combinations or single cosmids rescue). Other approaches to clone
mei-2 are in progress, including RFLP analysis of
mei-2 alleles and antisense RNA injection of candidate gene sequences produced by the Genome Sequencing Consortium. Antisense experiments for one candidate, a
cdc25 homologue on KO6A5, produced dead embryos from injected mothers, a phenotype consistent with
mei-2. Upon close examination, a small percentage (~5%) of antisense embryos exhibit what appears to be an enlarged polar body, a frequent hallmark of meiotic spindle disruption. Progress on the identification of
mei-2, as well as genetic screens to generate null alleles, will be presented.